CARCINOMA OF ENDOMETRIUM (endometrioiod and serous carcinoma of uterine corpus).pptx

sizan11 168 views 23 slides Mar 09, 2024
Slide 1
Slide 1 of 23
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23

About This Presentation

carcinoma of Uterine corpus, carcinoma of endometrium
endometrioid carcinoma, definition epidemiology, etiology, pathogenesis, gross and microscopic morphological features, serous carcinoma, definition, etiology, gross and microscopic morphological features, clinical features


Slide Content

CARCINOMA OF ENDOMETRIUM Dr. Sizan Thapa MD Pathology

Lesson Plan Introduction Types Defination Epidemiology Etiopathogenesis Morphology Clinical Features

Most common invasive carcinoma of the female genital tract - esp advanced world Increase in incidence due to early detection and treatment of Cervical carcinoma Types 2 main types along with other less frequent types

Types Endometrioid carcinoma Serous carcinoma Clear cell carcinoma Mixed Mullerian tumor (Carcinosarcoma)

ENDOMETRIAL ENDOMETRIOID CARCINOMA DEFINATION Malignant epithelial neoplasm displaying varying proportions of glandular, papillary and solid architecture, with the neoplastic cells showing endometrioid differentiation.

EPIDEMIOLOGY Seventh most common tumor in females Second most common tumor of female genital tracts Incidence is higher in countries with high HDI than those with low HDI Varies from 1 - 25/ 100000 person Age: Perimenopausal women Percursor lesions Endometrial hyperplasia with atypia

PATHOGENESIS Estrogen excess in the setting of endometrial hyperplasia in perimenopausal women Associated with conditions leading to excess estrogen Obesity Estrogen secreting ovarian tumors Exogenous estrogen

Mutations in mismatch repair genes and PTEN (tumor supressor genes Early events in the development Mostly somatic mutations Women with germline mutation in PTEN (Cowden syndrome) and mismatch repair genes (Lynch syndrome) are at high risk TP53 mutations are seen but rare and late event Mutation --> increased signalling through PI3K/AKT pathway.

Increased expression of estrogen receptor dependent target genes in endometrial cells. Leads to tumor development and progression Mismatch repair genes mutations lead to rapid accumulation of mutations that may alter the cancer genes --> Derive tumor development

MORPHOLOGY Gross features Exophytic or diffusely infiltrative Varying degree of hemorrhage and necrosis Some may arise in lower uterine segment Spread by myometrial invasion then direct extension into adjacent structures Metastasis to regional lymph nodes and distant organs occurs late

Microscopic features 3 grades based on differentiation Mostly well differentiated Villoglandular architecture resembling proliferative endometrium Columnar cells with pseudostratified nuclei Nuclear atypia: mild to moderate Nucleoli: inconspicious Cytplasm: eosinophilic and granular

Grading FIGO system Grade I : < 5% solid part Grade II : 6-50 % solid part Grade III :> 50% solid part

CLINICAL FEATURES Abnormal uterine bleeding Postmenopausal bleeding Advanced disease : abdominal symptoms resembling those of Ovarian carcinoma.

SEROUS CARCINOMA OF ENDOMETRIUM DEFINATION Malignant carcinoma with diffuse, marked nuclear pleomorphism, typically exhibiting papillary and/or glandular growth patterns

EPIDEMIOLOGY 10% of all endometrial carcinomas Higher in black women High risk: multiparity, history of breast cancer, tamoxifen use, pelvic irradiation Age : elderly post menopausal women

PATHOGENESIS Arise in a setting of atrophic endometrium or endometrial polyp Precursor lesion : Serous endometrial intraepithelial carcinoma (SEIC) Majority exhibit TP53 mutation--> Altered p53 function

MORPHOLOGY Gross Features Variable May look overtly invasive into myometrium Polyp may be present

Microscopic Features Complex papillary and/or glandular architecture Glands are typically elongated, irregular with slit like lumen High grade cytology with marked nuclear pleomorphism, macronucleoli and mitosis Multinucleated tumor giant cells and psammomatous calcifications may be seen IHC : diffuse staining for p53

CLINICAL FEATURES Presents with post menopausal bleeding May present with features of lymph node metastasis or distant metastasis to other organs

Thank you